We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWW icon
2876
Outdoor Holding Co
POWW
$255M
$11.1K ﹤0.01%
6,601
GEOS icon
2877
Geospace Technologies
GEOS
$66.5M
$11.1K ﹤0.01%
+1,231
New +$13.8K
RGLS
2878
DELISTED
Regulus Therapeutics
RGLS
$11K ﹤0.01%
+6,187
New +$14.4K
GTHX
2879
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$11K ﹤0.01%
+4,834
New +$18.5K
CVRX icon
2880
CVRx
CVRX
$78.3M
$11K ﹤0.01%
918
GRID
2881
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$12.3B
$11K ﹤0.01%
95
VERU icon
2882
Veru
VERU
$46M
$10.9K ﹤0.01%
+1,294
New +$15K
REKR icon
2883
Rekor Systems
REKR
$97.6M
$10.8K ﹤0.01%
+6,961
New +$12.2K
AGZ icon
2884
iShares Agency Bond ETF
AGZ
$566M
$10.8K ﹤0.01%
100
VTYX
2885
DELISTED
Ventyx Biosciences
VTYX
$10.7K ﹤0.01%
4,650
BWFG icon
2886
Bankwell Financial Group
BWFG
$542M
$10.7K ﹤0.01%
423
QIPT
2887
DELISTED
Quipt Home Medical
QIPT
$10.7K ﹤0.01%
3,332
LFCR icon
2888
Lifecore Biomedical
LFCR
$179M
$10.7K ﹤0.01%
+2,087
New +$12.4K
JAKK icon
2889
Jakks Pacific
JAKK
$294M
$10.7K ﹤0.01%
597
AMTX icon
2890
Aemetis
AMTX
$126M
$10.7K ﹤0.01%
+3,550
New +$13.5K
LCTX icon
2891
Lineage Cell Therapeutics
LCTX
$268M
$10.6K ﹤0.01%
10,656
KRT icon
2892
Karat Packaging
KRT
$953M
$10.6K ﹤0.01%
359
QTTB icon
2893
Q32 Bio
QTTB
$458M
$10.6K ﹤0.01%
+591
New +$14.1K
TSQ icon
2894
Townsquare Media
TSQ
$104M
$10.6K ﹤0.01%
965
RMNI icon
2895
Rimini Street
RMNI
$470M
$10.6K ﹤0.01%
3,438
INMB icon
2896
INmune Bio
INMB
$57.7M
$10.5K ﹤0.01%
+1,196
New +$11.8K
CPSS icon
2897
Consumer Portfolio Services
CPSS
$208M
$10.5K ﹤0.01%
1,073
TAYD icon
2898
Taylor Devices
TAYD
$170M
$10.5K ﹤0.01%
+233
New +$11.3K
LCUT icon
2899
Lifetime Brands
LCUT
$220M
$10.5K ﹤0.01%
+1,219
New +$12.2K
ULBI icon
2900
Ultralife
ULBI
$124M
$10.5K ﹤0.01%
+986
New +$10.5K

Similar funds

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.